Someone searches mosquito repellent for dengue fever — usually misspelled, usually in a hurry — on the third evening in a row that a neighbour has been carried out to an ambulance. Or a procurement officer in a Gulf municipality is reading a dengue alert and asking what to put on a purchase order. Or a distributor in Dhaka, Jakarta or Lagos is trying to work out which category on his shelf is about to move.
All three are asking the same question in different vocabularies: does the bottle on the shelf actually do anything about the disease, or only about the biting? The honest answer is more useful than the marketing answer, and it has four parts. A repellent does real work, and it does only that work. It is regulated as a pesticide, not as a health supplement, and its label cannot legally say what most shoppers assume it says. Its protection is measured in hours and it expires on a person, not in a bottle. And the mosquito that transmits dengue — Aedes aegypti — lives inside buildings, bites in daylight, and breeds in a bottle cap, which means a layer applied to one person’s forearm at 7 a.m. does not touch the population that took up residence in the hallway.
The World Health Organization states the position plainly: “Prevention and control of dengue rely on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue.” That sentence is the ceiling for every claim in this category. Repellents, coils, screens, container clearance and indoor devices are all vector control, and vector control is a stack of layers — not a hero product.
We manufacture electric mosquito killer lamps for importers, wholesalers, distributors, OEM brands and commercial facilities, so we are not a neutral party in this argument. We are also the party whose customers come back and ask why the bedroom is still being bitten after a full pharmacy shelf of repellent was bought. This guide is written for that conversation: what the evidence-based active ingredients are, what concentration actually buys you, why the label is so conservative, where the repellent layer stops, and which layer has to pick up from there.
What a mosquito repellent is, technically
A repellent is not a poison and not a trap. Applied to skin or clothing, an active ingredient interferes with the host-seeking cues a female mosquito uses to land and probe — carbon dioxide plume, odour profile, heat and moisture gradients — so that she arrives, does not find a landing site she can commit to, and leaves. Nothing is killed. The mosquito you did not get bitten by this afternoon is very likely still alive, still resting behind your curtain, and still looking for somebody else.
That distinction is the single most important thing for a buyer to understand, because it determines what the product is for. A repellent manages human exposure. It does not manage mosquito density. Those two jobs need different tools, and a shop that stocks only one of them is selling half an answer.
The second thing that surprises buyers is the regulatory category. In the United States, the Environmental Protection Agency is explicit: “Before they can be marketed, most skin-applied repellents must be registered by EPA. EPA registration of skin-applied repellent products indicates that they have been evaluated and approved for human safety and effectiveness when applied according to instructions on the label.” A skin-applied repellent is a pesticide. It is not a cosmetic and it is not a wellness product. Classification differs by destination, but in most regulated markets a product that makes a repellency claim is handled under pesticide or biocidal product law rather than under general consumer goods law — confirm which applies before you commit to a range.
For an importer or an OEM brand that is a hard gate on the whole project. Before you commit to a mould, a carton design or a first container, find out which ministry registers topical repellents in your destination market, what evidence the registration dossier requires, whose name goes on the certificate, and how long the approval takes. If the answer is that the product would arrive six months after the season it was bought for, the cheapest unit price in the quotation is not the cheapest landed cost.
The six active ingredients that agencies actually name
Ignore advertising and read the ingredient line. CDC — the US Centers for Disease Control and Prevention — publishes a short list of actives it considers evidence-based, and tells shoppers to identify the product by its EPA registration number rather than by its scent. CDC’s wording: “Use EPA-registered insect repellents with one of the following active ingredients. When used as directed, EPA-registered insect repellents are proven safe and effective, even for pregnant and breastfeeding women.”
The six actives CDC names are DEET, picaridin (sold as icaridin outside the United States), IR3535, oil of lemon eucalyptus (OLE), para-menthane-diol (PMD) and 2-undecanone. Note that CDC lists OLE and PMD separately: OLE is the plant-derived extract, PMD is the single molecule, and EPA treats them as separately regulated chemicals.
EPA’s own ingredient register adds commercial colour that a category planner will find more useful than any positioning deck. Product counts registered against the actives, as published on EPA’s skin-applied repellent ingredients page (updated January 2026): DEET carries more than 500 registered products; IR3535 and picaridin each carry roughly four to five times fewer; OLE, PMD and 2-undecanone sit in single or low double digits. Catnip oil and oil of citronella also appear on the registered list, with citronella carrying only three registered products — while the same ingredient is widely sold in unregistered bottles.
That gap between “registered” and “on the shelf” is where most of the confusion in this category lives, and EPA does not hide it. On unregistered products, EPA explains that the active ingredients were evaluated in the 1990s for safety, judged minimal-risk at the concentrations found in products, and therefore exempted from registration — and then adds the sentence that matters: “Note that products made from these ingredients have not been evaluated for effectiveness.”
CDC puts it even more bluntly, and this is the phrasing we would use on any shelf talker: “We do not know the effectiveness of non-EPA registered insect repellents, including some natural repellents.” It does not say they fail. It says nobody knows. For a brand selling into a market where consumers compare “natural” against “chemical” on the packaging, that is the whole compliance conversation in one line: you may sell the gentleness story, but you may not borrow an efficacy story that no regulator granted you.
Two label details that get missed at specification stage
First, age. CDC’s instruction is unambiguous: “Do not use products containing OLE or PMD on children under 3 years old.” If a carton, an insert card or a marketplace listing goes to a family-facing SKU without that warning, the recall risk sits with whoever put the label on it.
Second, where it goes. CDC’s current guidance includes “Do not apply repellent on the skin under clothing,” alongside “Always follow the product label instructions” and “Reapply repellent as directed.” A formulation intended for fabric treatment and a formulation intended for skin are different products with different dossiers. If an OEM enquiry arrives at a factory asking for one liquid that does both, that is a sign the buyer has not yet thought about registration.
What concentration actually buys you
Concentration is not a quality score. It is a duration control, and it has a ceiling. EPA states the relationship directly for the most-used active: “Studies in EPA’s database indicate that DEET repels ticks for about two to ten hours, and mosquitoes from two to twelve hours depending on the percentage of DEET in the product.” A ten-hour claim and a two-hour claim can be the same molecule.
The shape of the curve matters for line planning. A CDC technical update from 2008 — older guidance, cited here for the principle rather than as a current recommendation — describes it as follows: “In general, higher concentrations of active ingredient provide longer duration of protection, regardless of the active ingredient, although concentrations above ~50% do not offer a marked increase in protection time. Products with <10% active ingredient may offer only limited protection, often from 1-2 hours.”
Two commercial conclusions follow, and neither of them is about efficacy. Above roughly half the formula you are paying for weight in the bottle, not hours on the skin — which is why a 98% DEET product is a niche item for extreme exposure rather than a premium version of a 30% one. Below roughly ten per cent you have a product that must be re-applied on a short cycle, which is fine for a low-risk evening on a balcony and inadequate as the sole layer in a household with an active dengue cluster. The rational range architecture is therefore duration-graded: a gentle daily-wear SKU, a working-length SKU around 20–30 per cent, and a long-duration SKU for field, clinics and outdoor shift work — each sold on its label interval, not on a strength adjective.
Why the same bottle gets five-star and one-star reviews
Because duration is not a property of the liquid alone. The same CDC technical document lists the variables: “repellent efficacy and duration of protection vary considerably among products and among mosquito species and are markedly affected by ambient temperature, amount of perspiration, exposure to water, abrasive removal, and other factors.” EPA’s current safe-use page adds the factor that generates most of the argument in a review section: effectiveness varies with “Physical activity/perspiration. Water exposure. Air temperature. How attractive you are to mosquitoes and ticks; every person is different.”
That last line is worth putting in the FAQ on your own product page. Two honest answers to “why did this not work for me” are that the user sweated through the protection interval, or that they are genuinely more attractive to host-seeking females than the test panel average. Neither answer is a defect, and a brand that says so up front spends far fewer margins on returns.
The practical rule for users, in CDC’s own words: “if you start to get mosquito bites reapply the repellent according to the label instructions or remove yourself from the area with biting insects if possible.” Bites returning is the sensor. Not a clock, not a smell, not a marketing claim of all-day coverage.
Why no label in this category may say “prevents dengue”
This is the part a distributor needs before a marketplace takedown, not after. EPA, on its own page about using repellent products against mosquito-borne illness, frames the category with deliberate narrowness: “Insect repellents are one part of a more comprehensive program to control mosquitoes that transmit diseases such as dengue or Zika. Avoiding or preventing bites can help prevent transmission of dengue and any other vector-borne diseases.”
Read the two clauses in order. First, repellents are one part of a programme — EPA chose that phrase itself. Second, the mechanism runs through bite avoidance, which can help. That is an exposure statement, not a performance guarantee, and it is the outermost boundary any honest claim in this category can occupy. You will notice what is absent: no agency figure for “household transmission reduced by X per cent,” because we could not find any first-party source that publishes one. A number of that shape on a carton is invented at the factory, and the liability lands at the import.
It also explains the wording discipline you will see from established brands. They say “helps protect against mosquito bites,” because that is the claim their dossier supports. A supplier offering to print “dengue protection” on a private-label bottle is not being generous; they are handing you an enforcement file. Claims that imply complete protection are precisely the kind that regulators remove first in most controlled-product regimes, and a marketplace listing is judged the same way even where the statute differs. Get the permitted claim wording in writing from your local registrant or regulatory consultant before artwork is approved — not after the carton is printed.
The reason one layer cannot hold: the dengue mosquito is a housemate
Behaviour is the whole story in this category, and Aedes aegypti behaves nothing like the mosquito most buyers picture. WHO describes it as a “daytime feeder” whose “peak biting periods are early in the morning and in the evening before dusk”, and draws the operational conclusion itself: “Hence, a person can get bitten at home or at work.” This is not a night pest that a bed net and an overnight coil handle. CDC is broader still: “Aedes species mosquitoes can bite during the day and night.”
It also lives indoors. WHO: “Adult mosquitoes usually rest indoors in dark areas (closets, under beds, behind curtains). Here it is protected from wind, rain and most predators, which increases its life expectancy and the probability that it will live long enough to pick up a virus from one person and pass it on to the next.” CDC gives the same picture in operational terms: “Mosquitoes rest in dark, humid places like under sinks, in showers, in closets, under furniture, or in the laundry room. Mosquitoes entering your house from outdoors can start laying eggs indoors.”
And it breeds inside the boundary that any outdoor service stops at. WHO: “The dengue mosquito lays its eggs in water-filled containers inside the house and surrounding areas of dwellings (this includes non-used bottles, containers, discarded waste, old tyres etc. which hold water).” CDC’s examples are smaller still: “containers that hold water, like buckets, bowls, animal dishes, flowerpots, and vases” — and “Mosquitoes only need a small amount of water to lay eggs.”
Three details in that biology decide what a control programme has to look like:
- The eggs survive drought. CDC: “Eggs can survive drying out for up to 8 months.” They are laid on the container wall above the waterline, so pouring the water out leaves the next generation glued to the plastic. Dumping is not enough; the container has to be scrubbed.
- The generation is short. CDC: “A mosquito egg takes 7–10 days to develop into an adult mosquito.” That is the entire biological justification for a weekly interval. Anything done every two weeks is being done one generation late.
- One female bites more than once. WHO: “Aedes aegypti has evolved into an intermittent biter and prefers to bite more than one person during the feeding period. This mechanism has made Aedes aegypti a very highly efficient epidemic vector mosquito.” A single rested female in a hallway is not one bite, it is a distribution event across a household.
Now put a repellent back into that picture. It protects the person wearing it, on the skin she covered, for the interval on the label. It does nothing to the female resting behind the curtain, nothing to the eggs on the water butt wall in the courtyard, nothing to the child whose forearm was not covered, and nothing at all the moment the protection interval lapses. WHO’s own hierarchy reflects exactly this, and it puts source reduction first: “The best preventive measure for areas infested with Aedes mosquito is to eliminate the mosquitoes’ egg laying sites – called source reduction.”
The stack, in the order the evidence ranks it
WHO’s prevention guidance is unusually convenient for a category planner because it puts personal protection and environmental measures in one place, and it does not rank a single product. On the protection side it lists “clothes that cover as much of your body as possible; mosquito nets, ideally sprayed with insect repellent, if sleeping during the day; window screens; mosquito repellents (containing DEET, Picaridin or IR3535); and coils and vaporizers.” On the breeding side it lists environmental management, waste disposal, and covering, emptying and cleaning domestic water storage “on a weekly basis”.
On the question of whether these layers are interchangeable, the agencies are more direct than any vendor would be. EPA, on what else works alongside repellent: “You can, for example, exclude mosquitoes from your home by using window and door screens. Dressing in light-colored clothing, long pants, and long sleeves, avoiding areas where mosquitoes are present, and taking other actions such as removing sources of standing water to prevent breeding can also help.” And CDC, on the strongest single indoor measure available to a household: “Using only an indoor insecticide will not keep your home free of mosquitoes.”
If the agency that regulates pesticides and the agency that runs public health will both say that one layer is not enough, a category built on one layer is a category with a built-in disappointment cycle. The four layers below are the structure we would build a shelf, a catalogue or a facility programme around.
| Layer | Job it does | What it cannot do | Category it maps to |
|---|---|---|---|
| 1. Source reduction | Removes the next generation before it flies; WHO’s stated first measure | Zero effect on adults already resting indoors; needs weekly discipline and neighbourhood participation | Service, education, community programme — not a SKU |
| 2. Exclusion | Stops the indoor population reaching the person: screens, sealed gaps, air conditioning, daytime nets | Only works while the barrier stays closed and intact; useless outdoors | Screens, door closers, curtains, netting |
| 3. Personal repellent | Reduces bites on the covered person, including outdoors where no other layer exists | Protects one wearer for a label interval; no effect on density; needs re-application | DEET, picaridin, IR3535, OLE/PMD, 2-undecanone; treated clothing |
| 4. Indoor adult reduction | Lowers the number of biting adults present in the room people actually occupy | Does not replace layers 1–3; no agency endorsement of a disease-outcome claim | Aerosols, coils and vaporizers, electric insect light traps |
The layer most sellers skip is the first one, because you cannot invoice it. WHO is clear that it is where the leverage is, and adds the mechanism that makes household-level products a market rather than a hobby: “Community participation is the key to dengue prevention. As every household aims to reduce vector density, the transmission rate will decrease or even stop.” Note the modest verb — aims to. Even WHO does not promise a result per household.
Where an electric mosquito killer lamp honestly fits
Layer 4 is the layer we manufacture, so this is the section where we have the most to lose by overstating — and the reason we would rather state the evidence than borrow someone else’s confidence.
Start with what we could not find. We searched the WHO dengue fact sheet and dengue Q&A, WHO’s vector-borne diseases fact sheet, the CDC mosquitoes and dengue sections, and EPA’s entire insect repellents section. None of them evaluates, endorses or quantifies the efficacy of a consumer ultraviolet light trap against dengue transmission. WHO’s list of household measures stops at “coils and vaporizers” and aerosols, and its wording for those is “may also reduce biting activity”. CDC discusses screens, air conditioning, larviciding and adulticiding. EPA’s only statement about lamps is a caution against reading too much into lighting: “Replace your outdoor lights with yellow ‘bug’ lights, which tend to attract fewer mosquitoes than ordinary lights. The yellow lights are NOT repellents, however.”
The one first-party study we did find is a 2021 peer-reviewed test in the Journal of the American Mosquito Control Association, which opened by noting that “the light traps claim they are powerful, but research and evaluation are lacking” and then measured five commercial light traps in greenhouse conditions. Catch composition was 51.76 per cent Culex quinquefasciatus, 25.29 per cent Aedes albopictus, 14.12 per cent Anopheles sinensis and 8.82 per cent other flying insects. And on the specification most brochures lead with: “the ultraviolet wavelength (395–400 nm) used by the traps did not impact mosquito catch rates.”
We publish that because it is the correct buying instruction, not despite it. A light trap is an indoor density and nuisance-biting tool whose performance is driven by how the insect is drawn in and how it is dispatched — entry geometry, grid design, run-time, coverage per watt, and how serviceable the unit is after ten thousand deaths. It is not an Aedes-specific weapon and it is not a personal protective device, and any supplier who tells you a wavelength number is the reason a trap works is selling you a spec sheet. For our own read on that mechanism we wrote a separate piece on why 365 nm is used in electric mosquito killers, and a buyer-side checklist on what B2B buyers should look for.
Within layer 4 our units are plug-in indoor appliances: ultraviolet attraction into an electrocution zone running at 1800 V, in 10 W, 20 W, 30 W and 40 W configurations, built for continuous operation in rooms, dining floors, lobbies, clinics, warehouses and processing areas. They are not an outdoor product — open perimeter, wind, competing CO2 and human odour plumes put the mosquito’s attention somewhere else entirely — and they carry no repellency claim, because a device that kills what arrives cannot make an approaching insect not arrive. Classification of electrical insect light devices differs by market, so confirm the regulatory category with your own authority before listing one; do not assume it travels with the same dossier as a repellent, in either direction.
How the two categories differ commercially is just as important as how they differ technically, and it is the argument a distributor should be able to make to a retail buyer without raising voice or price.
| Dimension | Skin-applied repellent | Indoor electric unit |
|---|---|---|
| Job | Reduce bites on the wearer | Reduce biting adults present in a room |
| Where it works | Indoors and outdoors | Indoors only |
| Protection window | Label interval, hours, re-applied | Continuous while powered |
| Consumption model | Fast repeat purchase, short shelf life | One-off, plus tube and maintenance cycles |
| Regulatory load | Pesticide registration before marketing | Market-specific; verify separately |
| Fails when | Sweat, water, abrasion, interval lapse | Doors open, room unused, unit under-watted |
The last row is the one that prevents a returns argument. A repellent fails on the body. A device fails on the room: a dining floor with doors propped all evening, a unit switched off in the day shift, one 20 W appliance covering a hall that needs four. Both failure modes are installation and behaviour problems, which is why the sell-through material matters as much as the SKU.
Running cost without a price list
Buyers ask us for numbers we are not in a position to invent, because landed cost, duty, local electricity tariff and retail margin are all theirs. What can be done honestly is the physical arithmetic, which is the part that actually decides whether a programme is affordable before anyone quotes.
A repellent is priced per application, and applications are driven by the label interval. If the interval is shorter than the exposure period, the day consumes more than one application per person. Add sweat, hand-washing and clothing friction — all of which EPA lists as duration reducers — and a household of four on a two-hour interval burns through a small bottle in a fortnight, which is why repellent is a genuine consumable category with a real reorder rhythm rather than a seasonal impulse buy.
An indoor electric unit is priced once and consumes energy continuously. On our published ratings, a 20 W appliance run twelve hours a day draws 240 Wh a day, which is 7.2 kWh over a thirty-day month; a 40 W unit on the same schedule draws 480 Wh a day, or 14.4 kWh a month. A 10 W unit running around the clock lands on the same 240 Wh a day. Multiply by your own tariff and the operating line closes without a single estimated figure. The recurring costs after that are UV tube replacement on the maintenance cycle and cleaning the collection tray — both of which are why we build units to be opened by hand.
Set side by side, the two categories have opposite cost shapes: one has no capital cost and a compounding unit cost, the other has a capital cost and a slow tail. Neither number is a substitute for the other, which is also true of what they buy. For a facility evaluating whether to buy devices or increase spray frequency, we covered that comparison in electric mosquito killer versus chemical mosquito control, and for the outdoor-service question that most facility teams ask first, what mosquito spraying actually kills and when they come back.
What the demand curve looks like from the supply side
A distributor justifying a category to a buyer, or a lender, should not have to borrow our optimism. WHO’s own numbers are more useful than any market report and are free to cite.
- Scale. “About half of the world’s population is now at risk of dengue, with an estimated 100–400 million infections occurring each year.” A separate modelling study cited on the same page puts the at-risk figure at 5.6 billion people for dengue and other arboviruses — a larger, modelled number, and not interchangeable with the first.
- Trend. “The incidence of dengue has grown dramatically worldwide in recent decades, with the number of cases reported to WHO increasing from 505 430 cases in 2000 to 14.6 million in 2024.”
- Peak. “During 2024, ongoing transmission, combined with an unexpected spike in dengue cases, resulted in a historic high of over 14.6 million cases and more than 12 000 dengue-related deaths reported.”
- Continuation. “From January to July 2025, over 4 million cases and over 3000 deaths have been reported to WHO from 97 countries.”
- Addressable map. “The disease is now endemic in more than 100 countries.”
The line worth reading twice before you build a range is the last one. More than 100 endemic countries is a distribution plan, not a climate description — it is the difference between selling into a season and selling into a permanent addressable market, and it is why WHO lists among the drivers of spread “the changing distribution of the responsible vectors (chiefly Aedes aegypti and Aedes albopictus), especially in previously dengue-naive countries”. Dengue has already arrived in Europe as a reporting category: “In 2024, 308 cases were reported to WHO from three European countries (France, Italy and Spain)”, with a further 1,291 cases and four deaths in the French overseas territories of Mayotte and Réunion.
For a buyer in a market that has never had a dengue season, that sentence is the reason a vector-control aisle starts appearing in hardware and grocery chains before the first local transmission cluster is documented. Demand in this category is written several months ahead of the season that monetises it.
Vaccines exist, and they did not close the gap
Importers in endemic markets get this question from hospitals and from government buyers, and the accurate answer helps rather than hurts the category. WHO’s current statement: “Currently, one vaccine (QDenga) is available and licensed in some countries. However, it is recommended only for those aged 6–16 years in high transmission settings. Several additional vaccines are under evaluation.” On the schedule, WHO’s Q&A gives “a 2-dose series, three months apart, given to specific age groups and in specific circumstances”, and notes it does not currently recommend programme use below age six because of lower efficacy in that group.
The conclusion is WHO’s own, and it is the sentence to put in a tender response: “Vaccination against dengue should be viewed as part of an integrated strategy to control the disease, including vector control, proper case management, community education and community engagement. Comprehensive vector control must remain a critical component of dengue control programmes.” A vaccine licensed for a narrow age band in high-transmission settings leaves every adult, every age band above sixteen, and every low-and-moderate transmission market standing on vector control. Which is the market.
Turning this into a channel, not just a catalogue page
The structure above is also a route to customers who do not currently know you exist. A pest control operator selling residential and venue programmes has exactly the problem this article describes: a knockdown service that decays in days, an indoor adult population the spray truck never reached, and a client who judges the contract on the third evening. Container management plus exclusion plus an indoor device layer is a differentiated programme those operators can price, and it is a repeat relationship rather than a one-off truck roll.
We wrote the two pieces we hand them: what local mosquito control services do and do not fix, and what actually works in indoor commercial spaces. For the hospitality and food-service buying committee specifically, the honest performance picture is in how effective electric mosquito killers are in hotels and restaurants, and the species biology behind the whole argument is how long mosquitoes actually live.
Practically, three enquiries reach us and each needs a different answer: distributors and wholesalers building or extending a vector-control aisle; OEM and ODM brands that need customisation on housing, colour, logo, packaging and tube configuration, with the development and tooling path documented on our services page; and facility buyers — hotels, restaurants, clinics, food processing, warehousing, property managers — who need model-to-environment matching rather than a catalogue. Pricing in every case is by enquiry, because it depends on model mix, volume, packaging and destination market. Start at contact us with the market, the channel and the annual volume you are planning; if you want to see the range first, it is on the products page, and who we are is on about us.
Frequently asked questions
Is there a specific mosquito repellent for dengue fever?
No product is a “dengue repellent”. There are repellents, and there is a mosquito that transmits dengue. Buy by active ingredient from the list CDC names — DEET, picaridin, IR3535, OLE, PMD or 2-undecanone — and by the protection interval on the label. That is the whole of what a shopper can verify at the shelf.
Which is better for dengue, DEET or picaridin?
Neither agency ranks one above the other, and both appear on CDC’s evidence-based list. What you can compare is duration against your real exposure, and tolerability: picaridin is generally chosen where a cosmetic feel matters and DEET where the longest interval is the requirement. Concentration drives duration; above roughly 50 per cent the extra concentration stops buying extra hours.
Does a repellent protect against dengue?
Avoiding bites can help prevent transmission — that is EPA’s wording, in the same sentence in which it calls repellents “one part of a more comprehensive program”. It does not follow that a repellent alone is protection, and no first-party agency figure quantifies household-level protection from repellent use. Anyone printing such a number invented it.
Are citronella and other natural repellents effective?
CDC: “We do not know the effectiveness of non-EPA registered insect repellents, including some natural repellents.” EPA explains why: the exempted botanical actives were assessed for safety in the 1990s and expressly “not been evaluated for effectiveness”. Selling them is legal. Borrowing an efficacy claim for them is not.
Do ultrasonic or app-controlled mosquito devices work?
We found no WHO, CDC or EPA assessment of consumer light traps against dengue transmission, and none for ultrasonic emitters, so we will not assert one either way. What we can say about light devices is measured: in the 2021 JAMCA trial of five commercial light traps, catch was dominated by Culex at 51.76 per cent with Aedes albopictus at 25.29 per cent, and the UV wavelength used did not affect catch rate. Buy layer 4 for indoor density and nuisance biting. Do not buy it as a substitute for layers 1 to 3.
Why is my family still getting bitten if we all wear repellent?
Because the adults are resting indoors, breeding in containers inside the dwelling, and biting at the two peaks — early morning and before dusk — when an interval applied at breakfast has already lapsed. Scrub the containers weekly, close the gaps, cover the skin, then reduce what is inside the room. Four layers, in that order.
Sources quoted in this article
Every institutional sentence above is quoted from a first-party page, and each link carries the date printed on that page. We have deliberately not summarised them into stronger claims than they make.
- World Health Organization — Dengue and severe dengue fact sheet (21 August 2025): global burden, at-risk population, endemic country count, 2024 peak, 2025 year-to-date, prevention measures, vaccine status.
- World Health Organization — Dengue and severe dengue questions and answers (2 October 2024): Aedes aegypti biting behaviour, indoor resting, breeding sites, source reduction, household protection stack, vaccine recommendation.
- US Centers for Disease Control and Prevention — Preventing Mosquito Bites (published 15 May 2024, reviewed 28 August 2024): the six evidence-based active ingredients, EPA Reg. No. guidance, OLE/PMD age limit, re-application instructions, natural repellents.
- US CDC — How Dengue Spreads (published 15 May 2024, updated 22 May 2025): human preference, indoor and outdoor living near people, day and night biting, container examples.
- US CDC — Life Cycle of Aedes Mosquitoes: small water volumes, eggs above the waterline, 8-month desiccation survival, 7–10 day development, flight range and species habitat split.
- US CDC — Mosquito Control at Home: indoor resting places, outdoor adulticide at resting sites, and the statement that indoor insecticide alone will not keep a home free of mosquitoes.
- US CDC — Updated Information regarding Mosquito Repellents (8 May 2008, legacy technical document): concentration–duration relationship and the factors that shorten protection time. Cited for mechanism only, and labelled by year in the text.
- US Environmental Protection Agency — Regulation of Skin-Applied Repellents (updated 25 June 2026): registration requirement, and the finding that exempted botanical ingredients were assessed for safety but not for effectiveness.
- US EPA — Skin-Applied Repellent Ingredients (updated 23 January 2026): registered actives and product counts.
- US EPA — DEET (updated 27 May 2026): protection duration range by concentration.
- US EPA — Using Insect Repellents Safely and Effectively (updated 3 November 2026): re-application and the variables that change effectiveness, including individual attractiveness.
- US EPA — Using Repellent Products to Protect against Mosquito-Borne Illnesses (updated 27 May 2026): repellents as one part of a comprehensive programme.
- US EPA — Tips to Prevent Mosquito Bites (updated 11 May 2026): yellow bug lights attract fewer mosquitoes and are not repellents.
- Huang R, Song H, Fang Q, Qian J, Zhang Y, Jiang H. Laboratory and Greenhouse Performance of Five Commercial Light Traps for Capturing Mosquitoes in China. Journal of the American Mosquito Control Association 37(4):250–255 (online 23 November 2021): catch composition and the finding that ultraviolet wavelength did not affect catch rate.
This article is general information for trade buyers, not medical advice. Dengue can become severe. Anyone with a fever after a mosquito bite in or near a transmission area should seek medical care and mention the mosquito exposure. Guidance quoted here is from the WHO dengue fact sheet and dengue Q&A, the WHO vector-borne diseases fact sheet, CDC pages on mosquito prevention, dengue transmission, Aedes life cycle and home mosquito control, and EPA pages on skin-applied repellent regulation, ingredients, DEET and safe use, with the page dates given in the text. Product decisions should follow the registration and labelling requirements of your own destination market.
